Avandia 4mg & 8mg film-coated Tablets
Use of this medicine has been suspended by the European medicines agency (EMA).
The following advice has been issued to patients and healthcare professionals:
- Prescribers should review the treatment of diabetic patients currently taking Avandia. The Chairman of the Commission on Human Medicines is sending a letter with advice to healthcare professionals, through the Department of Health's Central Alerting System.
- Patients currently taking Avandia should consult their doctor about alternative treatment.
- Patients should not stop treatment with Avandia (rosiglitazone) without consulting their doctor as it is helping to control their blood sugar levels.
Further information about the Europe-wide suspension of Avandia is provided by the UK medicines licensing agency, the Medicines and Healthcare products Regulatory Authority (MHRA).
http://www.mhra.gov.uk/NewsCentre/Pressreleases/CON094127